233 related articles for article (PubMed ID: 22982111)
1. Discovery of potential bladder cancer biomarkers by comparative urine proteomics and analysis.
Lei T; Zhao X; Jin S; Meng Q; Zhou H; Zhang M
Clin Genitourin Cancer; 2013 Mar; 11(1):56-62. PubMed ID: 22982111
[TBL] [Abstract][Full Text] [Related]
2. Searching cell-secreted proteomes for potential urinary bladder tumor markers.
Lin CY; Tsui KH; Yu CC; Yeh CW; Chang PL; Yung BY
Proteomics; 2006 Aug; 6(15):4381-9. PubMed ID: 16819731
[TBL] [Abstract][Full Text] [Related]
3. [Application of urinary proteomics in early diagnosis of bladder urothelial carcinoma].
Li HJ; Li CY; Zhang T; Chen JJ; Wang SX; Chang JW; Jiang SF; Zhang GL; Li JM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Apr; 31(4):262-5. PubMed ID: 23595302
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Apo-A1 as a potential bladder cancer biomarker by urine proteomics and analysis.
Li C; Li H; Zhang T; Li J; Liu L; Chang J
Biochem Biophys Res Commun; 2014 Apr; 446(4):1047-52. PubMed ID: 24661883
[TBL] [Abstract][Full Text] [Related]
5. Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach.
Orenes-Piñero E; Cortón M; González-Peramato P; Algaba F; Casal I; Serrano A; Sánchez-Carbayo M
J Proteome Res; 2007 Nov; 6(11):4440-8. PubMed ID: 17902641
[TBL] [Abstract][Full Text] [Related]
6. Bikunin loss in urine as useful marker for bladder carcinoma.
Tsui KH; Tang P; Lin CY; Chang PL; Chang CH; Yung BY
J Urol; 2010 Jan; 183(1):339-44. PubMed ID: 19914646
[TBL] [Abstract][Full Text] [Related]
7. Identification of differentially expressed proteins of gamma-ray irradiated rat intestinal epithelial IEC-6 cells by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry.
Bo Z; Yongping S; Fengchao W; Guoping A; Yongjiang W
Proteomics; 2005 Feb; 5(2):426-32. PubMed ID: 15700242
[TBL] [Abstract][Full Text] [Related]
8. Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers.
Saito M; Kimoto M; Araki T; Shimada Y; Fujii R; Oofusa K; Hide M; Usui T; Yoshizato K
Eur Urol; 2005 Nov; 48(5):865-71. PubMed ID: 15964125
[TBL] [Abstract][Full Text] [Related]
9. [Screen and identify of differential proteins expressed in the placenta of Down's syndrome].
Yan LY; Sun CJ; Wang X; Chen Y; Zhang WY
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):161-6. PubMed ID: 21575446
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology.
Chen YT; Chen CL; Chen HW; Chung T; Wu CC; Chen CD; Hsu CW; Chen MC; Tsui KH; Chang PL; Chang YS; Yu JS
J Proteome Res; 2010 Nov; 9(11):5803-15. PubMed ID: 20806971
[TBL] [Abstract][Full Text] [Related]
11. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
[TBL] [Abstract][Full Text] [Related]
12. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
13. Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer.
Irmak S; Tilki D; Heukeshoven J; Oliveira-Ferrer L; Friedrich M; Huland H; Ergün S
Proteomics; 2005 Nov; 5(16):4296-304. PubMed ID: 16196100
[TBL] [Abstract][Full Text] [Related]
14. Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer.
Bai Z; Ye Y; Liang B; Xu F; Zhang H; Zhang Y; Peng J; Shen D; Cui Z; Zhang Z; Wang S
Int J Oncol; 2011 Feb; 38(2):375-83. PubMed ID: 21165559
[TBL] [Abstract][Full Text] [Related]
15. Investigation of serum proteome alterations in human glioblastoma multiforme.
Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S
Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992
[TBL] [Abstract][Full Text] [Related]
16. [Comparative proteomics of the serum in patients with nasopharyngeal carcinoma: a study with two-dimensional electrophoresis and MALDI-TOF-MS].
Liao QL; Chen XD; Zhao L; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):154-8. PubMed ID: 18250030
[TBL] [Abstract][Full Text] [Related]
17. Potential plasma biomarkers of bladder cancer identified by proteomic analysis: A pilot study.
Lemańska-Perek A; Lis-Kuberka J; Lepczyński A; Dratwa-Chałupnik A; Tupikowski K; Kątnik-Prastowska I; Ożgo M
Adv Clin Exp Med; 2019 Mar; 28(3):339-346. PubMed ID: 29963784
[TBL] [Abstract][Full Text] [Related]
18. Proteomic identification of plasma biomarkers in uterine leiomyoma.
Lin CP; Chen YW; Liu WH; Chou HC; Chang YP; Lin ST; Li JM; Jian SF; Lee YR; Chan HL
Mol Biosyst; 2012 Apr; 8(4):1136-45. PubMed ID: 22193648
[TBL] [Abstract][Full Text] [Related]
19. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
[TBL] [Abstract][Full Text] [Related]
20. Towards a comprehensive database of proteins from the urine of patients with bladder cancer.
Rasmussen HH; Orntoft TF; Wolf H; Celis JE
J Urol; 1996 Jun; 155(6):2113-9. PubMed ID: 8618346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
